Share on StockTwits

Analysts at BTIG Research assumed coverage on shares of Masimo Corp. (NASDAQ:MASI) in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $32.00 price target on the stock. BTIG Research’s price target points to a potential upside of 33.61% from the stock’s previous close.

Shares of Masimo Corp. (NASDAQ:MASI) traded up 1.25% during mid-day trading on Tuesday, hitting $24.25. The stock had a trading volume of 366,615 shares. Masimo Corp. has a one year low of $21.45 and a one year high of $32.20. The stock has a 50-day moving average of $23.98 and a 200-day moving average of $26.67. The company has a market cap of $1.376 billion and a P/E ratio of 21.18.

Masimo Corp. (NASDAQ:MASI) last released its earnings data on Wednesday, April 30th. The company reported $0.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.29 by $0.01. The company had revenue of $139.80 million for the quarter, compared to the consensus estimate of $144.01 million. During the same quarter last year, the company posted $0.28 earnings per share. Analysts expect that Masimo Corp. will post $1.29 EPS for the current fiscal year.

MASI has been the subject of a number of other recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Masimo Corp. in a research note on Friday, June 13th. They now have a $25.00 price target on the stock. Analysts at Citigroup Inc. reiterated a “hold” rating on shares of Masimo Corp. in a research note on Friday, May 2nd. They now have a $29.00 price target on the stock. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Masimo Corp. presently has an average rating of “Hold” and an average target price of $28.00.

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.